October is Breast Cancer Awareness Month - early detection and the right questions can empower patients to make informed decisions and improve outcomes.

Oncology became more than just a profession; it is a humanitarian mission I practice with a spirit of hope, believing that ...

However, it was the late-breaking Phase 1/2 data from the SOHO-01 study of sevabertinib (BAY 2927088) in advanced HER2-mutant non-small cell lung cancer that pharmaphorum spoke about with Dr Nicoletta ...

He mentored medical students at UC, held numerous board positions, and remains the top fundraiser for Blood Cancer United's Ohio River Valley Region.He was the face of Peter's Pals at Light the Night.

An MCED blood test increased screenable cancer detection more than 7-fold when added to the US Preventive Services Task Force (USPSTF) A/B recommended screening.

October is Breast Cancer Awareness Month, and cancer awareness starts with general breast awareness. Dr. Julie Nangia, ...

Hevia and Sousa discuss the landscape of unmet needs in metastatic castration-resistant prostate cancer, what the new data ...

The Galleri test aims to find fragments of DNA in a person’s blood that can indicate the presence of a cancerous tumor.

Three years after topping the Medical Technologist Licensure Examination (MTLE) in 2022, the University of Santo Tomas (UST) ...

A blood test that screens for more than 50 cancers is correct in 62% of cases where it thinks people may have the disease, a ...

Dr. Issam "Sam" Makhoul's medical career has taken him from Lattakia, Syria; to Paris; then to Little Rock; by way of Hershey ...

Atezolizumab improved DFS and OS in ctDNA-positive MIBC patients, with a median DFS of 9.9 months vs 4.8 months for placebo. Serial ctDNA testing may offer a more accurate assessment of MRD and early ...